Donor methylenetetrahydrofolate reductase genotype is associated with graft-versus-host disease in hematopoietic stem cell transplant patients treated with methotrexate
Nicholas M. Murphy(Genetic Technologies (Australia)), Brian D. Tait(Australian Red Cross Lifeblood), Jeff Szer(The Royal Melbourne Hospital), Mary Diviney(Australian Red Cross Lifeblood), Rhonda Holdsworth(Australian Red Cross Lifeblood), Andrew Grigg(The Royal Melbourne Hospital), Peter Bardy(Royal Adelaide Hospital), R Hoyt(The Royal Melbourne Hospital), Bradley J King(Melbourne Health), Lachlan MacGregor(Melbourne Health), James McCluskey(Peter Doherty Institute)
Cited by 38
Related Papers
The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
|New England Journal of Medicine|2006|1.3k
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease
|New England Journal of Medicine|2020|859